MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaip.2020.07.033

Медицинская библиотека · The journal of allergy and clinical immunology. In practice · 2020

Asthma Medication Use and Risk of Birth Defects: National Birth Defects Prevention Study, 1997-2011.

Howley Meredith M, Papadopoulos Eleni A, Van Bennekom Carla M, Van Zutphen Alissa R, Carmichael Suzan L, Munsie JeanPierre W, Herdt Michele L, Browne Marilyn L, National Birth Defects Prevention Study

СтатьяПоддержка службы здравоохранения СШАПеревод в очереди

Аннотация

BACKGROUND

Evidence regarding associations between maternal asthma medication use and birth defects is mixed.

OBJECTIVE

Estimate associations between asthma medciation use and 52 birth defects using National Birth Defects Prevention Study data from 1997 to 2011.

METHODS

We compared self-reported maternal asthma medication use for 28,481 birth defect cases and 10,894 nonmalformed controls. We calculated adjusted odds ratios (95% CIs) to estimate the risk of birth defects associated with early pregnancy asthma medication use (the month before through the third month of pregnancy), controlling for maternal age, race/ethnicity, body mass index, smoking, folic acid-containing supplement use, and parity. We calculated risks by medication groupings: bronchodilators, anti-inflammatories, and both.

RESULTS

Overall, 1304 (5%) case and 449 (4%) control women reported early pregnancy asthma medication use. We observed an association between asthma medication use and longitudinal limb deficiency (1.81; 95% CI, 1.27-2.58). Early pregnancy bronchodilator-only use was associated with cleft palate (1.50; 95% CI, 1.11-2.02), cleft lip (1.58; 95% CI, 1.12-2.23), longitudinal limb deficiency (2.35; 95% CI, 1.55-3.54), and truncus arteriosus (2.48; 95% CI, 1.13-5.42). Although early pregnancy anti-inflammatory-only use was not associated with the birth defects studied, use of both medications was associated with biliary atresia (3.60; 95% CI, 1.55-8.35) and pulmonary atresia (2.50; 95% CI, 1.09-5.78).

CONCLUSIONS

Consistent with previous National Birth Defects Prevention Study analyses, asthma medication use was not associated with most birth defects examined, but we observed modest risks for bronchodilator use and several birth defects. Our findings support maintaining adequate asthma treatment during pregnancy, because early pregnancy asthma exacerbations have been associated with adverse birth outcomes, including birth defects.

Для цитирования: Howley Meredith M, Papadopoulos Eleni A, Van Bennekom Carla M, Van Zutphen Alissa R, Carmichael Suzan L, Munsie JeanPierre W, Herdt Michele L, Browne Marilyn L, National Birth Defects Prevention Study. Asthma Medication Use and Risk of Birth Defects: National Birth Defects Prevention Study, 1997-2011.. The journal of allergy and clinical immunology. In practice. 2020. DOI: 10.1016/j.jaip.2020.07.033.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.